Obesity Surgery

, Volume 23, Issue 3, pp 384–390 | Cite as

Secondary Hyperparathyroidism, Vitamin D Sufficiency, and Serum Calcium 5 Years After Gastric Bypass and Duodenal Switch

  • Stephen HewittEmail author
  • Torgeir T. Søvik
  • Erlend T. Aasheim
  • Jon Kristinsson
  • Jørgen Jahnsen
  • Grethe S. Birketvedt
  • Thomas Bøhmer
  • Erik F. Eriksen
  • Tom Mala
Clinical Research



The prevalence of secondary hyperparathyroidism (SHPT) is high after bariatric surgery. Vitamin D is supplied to counteract SHPT and bone disease, and we studied vitamin D associations with SHPT.


We measured serum levels of 25-OH vitamin D and parathyroid hormone (PTH) 5 years after gastric bypass and duodenal switch. One hundred twenty-five patients were included, of whom 114 (91 %) had undergone gastric bypass and 11 (9 %) had undergone duodenal switch. SHPT was defined as PTH > 7.0 pmol/l in the absence of hypercalcemia. 25-OH vitamin D levels were divided into three categories: <50, 50–74, and ≥75 nmol/l. Serum ionized calcium, magnesium, phosphate, and creatinine were divided into tertiles.


Mean age ± SD was 44 ± 9 years at 5 years follow-up. Ninety out of 125 (72 %) patients were women. SHPT was present in 45 out of 114 (40 %) gastric bypass patients and in 11 out of 11 (100 %) duodenal switch patients. The prevalence was high in all vitamin D categories studied. An inverse association between ionized calcium and PTH was found. For the gastric bypass patients, the odds ratio for SHPT in the upper two tertiles of ionized calcium was 0.35; 95 % CI, 0.15–0.79; p = 0.011, compared with the lowest tertile. Supplements of vitamin D and calcium were not associated with a lower prevalence of SHPT at 5 years follow-up.


The prevalence of SHPT was high 5 years after gastric bypass and duodenal switch. SHPT was inversely associated with serum ionized calcium, but not with vitamin D. The supplementation used was insufficient to compensate for the impaired calcium absorption after surgery.


Secondary hyperparathyroidism Parathyroid hormone Vitamin D Calcium Hypocalcemia Bariatric surgery Gastric bypass Duodenal switch 



We are especially thankful to the whole multidisciplinary team at the Department of Morbid Obesity and Bariatric Surgery, Oslo University Hospital Aker for their participation and follow-up before and after surgery. We are also thankful to Peter Abusdal Torjesen and Solve Tjora at the Hormone Laboratory and the Central Laboratory, respectively, for reviewing the section with the methodological aspects of the serum analyses.

Conflict of Interest

Torgeir T Søvik received travel support from Johnson & Johnson. Jon Kristinsson received travel support from Covidien and Johnson & Johnson. Thomas Bøhmer received royalties from Nycomed Pharma. Erik Fink Eriksen has received travel support and speaker fees from Lilly, Novartis, Amgen, and IDS. Tom Mala has received speaker fees from Johnson & Johnson and travel support from Covedien. Stephen Hewitt, Erlend T Aasheim, Jørgen Jahnsen, and Grethe S Birketvedt did not report any form of conflicts of interest.


  1. 1.
    Sjøstrøm L, Narbro K, Sjøstrøm CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;8:741–52.CrossRefGoogle Scholar
  2. 2.
    Tucker ON, Szomstein S, Rosenthal RJ. Nutritional consequences of weight-loss surgery. Med Clin N Am. 2007;91:499–514.CrossRefPubMedGoogle Scholar
  3. 3.
    Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow-up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab. 2009;35:544–57.CrossRefPubMedGoogle Scholar
  4. 4.
    Mechanick JI, Kushner RF, Sugerman HJ, et al. AACE/TOS/ASMBS guidelines. Obesity. 2009;17:S1–S70.CrossRefPubMedGoogle Scholar
  5. 5.
    Aasheim ET, Hofsø D, Hjelmesæth J, et al. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr. 2008;87:862–9.Google Scholar
  6. 6.
    Aasheim ET, Björkman S, Søvik TT, et al. Vitamin status after bariatric surgery: a randomised study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90:15–22.CrossRefPubMedGoogle Scholar
  7. 7.
    Gasteyger C, Suter M, Gaillard RC, et al. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr. 2008;87:1128–33.PubMedGoogle Scholar
  8. 8.
    Søvik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch. Ann Intern Med. 2011;155:281–91.PubMedGoogle Scholar
  9. 9.
    DiGiorgi M, Daud A, Inabnet WB, et al. Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg. 2008;18:1144–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Signori C, Zalesin KC, Franklin B, et al. Effect of gastric bypass on vitamin D and secondary hyperparathyroidism. Obes Surg. 2010;20:949–52.CrossRefPubMedGoogle Scholar
  11. 11.
    Youssef Y, Richards WO, Sekhar N, et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc. 2007;21:1393–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Clements RH, Yellumahanhi K, Wesley M, et al. Hyperparathyroidism and vitamin D deficiency after laparoscopic gastric bypass. Am Surg. 2008;74(6):469–74.PubMedGoogle Scholar
  13. 13.
    Ybarra J, Sanches-Hernandez J, Gich I, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005;3:330–5.CrossRefGoogle Scholar
  14. 14.
    Vilarrasa N, San Jose P, Garcia I, et al. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg. 2011;21:465–72.CrossRefPubMedGoogle Scholar
  15. 15.
    Valderas JP, Soledad V, Solari S, et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Obes Surg. 2009;19:1132–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Balsa JA, Botella-Carratero JI, Peromingo R, et al. Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion. J Endocrinol Invest. 2008;31:845–50.PubMedGoogle Scholar
  17. 17.
    Topart P, Becouarn G, Salle A. Five-year follow-up after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2011;7:199–205.CrossRefPubMedGoogle Scholar
  18. 18.
    Johnson JM, Maher JW, DeMaria EJ, et al. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006;243:701–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Compher CW, Badellino K, Boullata JI. Vitamin D and the bariatric surgical patient: a review. Obes Surg. 2008;18:220–4.CrossRefPubMedGoogle Scholar
  20. 20.
    Hamoui N, Kim K, Anthone G, et al. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg. 2003;138:891–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Grethen E, McClintock R, Gupta CE, et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011;96:1320–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Bischoff-Ferrari HA. Optimal serum 25-OH-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol. 2008;624:55–71.CrossRefPubMedGoogle Scholar
  24. 24.
    Goldner WS, Stoner JA, Lyden E, et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg. 2009;19:173–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Carlin AM, Rao DS, Yager KM, et al. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis. 2009;5:444–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Srikanth MS, Quddusi S, Fox SR, et al. Correction of secondary hyperparathyroidism after distal gastric bypass using oral high dose vitamin D, calcitriol and calcium replacement. Surg Obes Relat Dis. 2005;1:271.Google Scholar
  27. 27.
    Nelson ML, Bolduc LM, Toder ME, et al. Correction of preoperative vitamin D deficiency after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2007;3:434–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Anonymous. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55:615S–619S.Google Scholar
  29. 29.
    Søvik TT, Taha O, Aasheim ET, et al. Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br J Surg. 2010;97(2):160–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4823–43.CrossRefPubMedGoogle Scholar
  31. 31.
    Bøhmer T. Magnesium deficiency. Tidsskr Nor Lægeforen. 1986;106:548–51.PubMedGoogle Scholar
  32. 32.
    Parfitt AM. The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int. 1997;52:3–9.CrossRefPubMedGoogle Scholar
  33. 33.
    McDuffie LA, Bucher BT, Erwein CR, et al. Intestinal adaptation after small bowel resection in human infants. J Pedatr Surg. 2011;46:1045–51.CrossRefGoogle Scholar
  34. 34.
    Tandapu P, Provost D, Adams-Huet B, et al. Comparison of the absorption of calcium carbonate and calcium citrate after Roux-en-Y gastric bypass. Obes Surg. 2009;19:1256–61.CrossRefGoogle Scholar
  35. 35.
    Harper J, Madan AK, Ternovits CA, et al. What happens to patients who do not follow-up after bariatric surgery? Am Surg. 2007;73:181–4.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2012

Authors and Affiliations

  • Stephen Hewitt
    • 1
    Email author
  • Torgeir T. Søvik
    • 2
    • 3
  • Erlend T. Aasheim
    • 4
  • Jon Kristinsson
    • 1
    • 2
  • Jørgen Jahnsen
    • 5
  • Grethe S. Birketvedt
    • 1
  • Thomas Bøhmer
    • 4
  • Erik F. Eriksen
    • 3
    • 4
  • Tom Mala
    • 1
    • 2
  1. 1.Department of Morbid Obesity and Bariatric Surgery, Department of MedicineOslo University Hospital AkerOsloNorway
  2. 2.Department of Gastrointestinal Surgery, Department of SurgeryOslo University Hospital AkerOsloNorway
  3. 3.Faculty of MedicineUniversity of OsloOsloNorway
  4. 4.Department of Endocrinology, Department of MedicineOslo University Hospital AkerOsloNorway
  5. 5.Department of Gastroenterology, Department of MedicineOslo University Hospital AkerOsloNorway

Personalised recommendations